Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Version
3.02
Revision date
2023-12-20
Product name
sodium hydroxide
Chemical name
sodium hydroxide
CAS No.
1310-73-2
REACH No
01-2119457892-27-xxxx
Emergency telephone
1-800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
Elementar Analysensysteme GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@elementar.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H290, H314, H315, H318, H319
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May be corrosive to metals. Causes severe skin burns and eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS05
Signal word
Danger
Hazard statements
H290 - May be corrosive to metals. H314 - Causes severe skin burns and eye damage.
Precautionary statements
P280 - Wear protective gloves, protective clothing, eye protection, face protection. P301+P330+P331+P310 - IF SWALLOWED: rinse mouth. Do NOT induce vomiting. Immediately call a POISON CENTER or doctor. P303+P361+P353+P310 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. Immediately call a POISON CENTER or doctor. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. P390 - Absorb spillage to prevent material damage. Listed on CLP Annex VI : EC Index-No.: 011-002-00-6
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605